Aimed Bio
0009K0StockKQ
27,200.00 ▲ +0.00%
Jun 12, 2026
0
Aimed Bio
27,200.00 ▲ +0.00%
Jun 12, 2026
0009K0StockKQ

About the company

Aimed Bio Inc. develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases. Its multidisciplinary platform offers antibody-drug conjugates, blood-brain barrier penetration, brain immune modulation, and patient-derived models (PDC/PDX). Aimed Bio Inc. was founded in 2018 and is based in Seoul, South Korea.

Arberion
Loading market data